An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I Study to Determine the Safety and; Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax) for the Treatment of Diabetic Foot Ulcer (DFU).

Trial Profile

An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I Study to Determine the Safety and; Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax) for the Treatment of Diabetic Foot Ulcer (DFU).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Esmolol (Primary)
  • Indications Diabetic foot ulcer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors NovaLead Pharma Pvt. Ltd
  • Most Recent Events

    • 27 Jan 2016 Status changed from active, no longer recruiting to completed, as reported on the company pipeline.
    • 26 Sep 2013 New source identified and integrated (Clinical Trials Registry - India: CTRI2013-07-003838).
    • 05 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top